| dc.contributor.author |
Taliyan, Rajeev |
|
| dc.date.accessioned |
2023-12-13T08:57:30Z |
|
| dc.date.available |
2023-12-13T08:57:30Z |
|
| dc.date.issued |
2016 |
|
| dc.identifier.uri |
https://www.ijp-online.com/article.asp?issn=0253-7613;year=2016;volume=48;issue=1;spage=59;epage=63;aulast=Mittal |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13398 |
|
| dc.description.abstract |
The signaling pathways upstream of glycogen synthase kinase-3β (GSK-3β) get reduced during ischemic preconditioning (IPC) in hyperlipidemic rat heart. Pioglitazone, an insulin sensitizer, exerts cardioprotection through GSK-3β. The objective of the study is to investigate the role of pioglitazone on the attenuated cardioprotective effect of IPC in hyperlipidemic rat heart. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Medknow |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
Creatinine kinase |
en_US |
| dc.subject |
Glycogen synthase kinase-3β |
en_US |
| dc.subject |
Ischemia-reperfusion |
en_US |
| dc.subject |
Lactate dehydrogenase |
en_US |
| dc.subject |
Myocardial injury |
en_US |
| dc.subject |
Pioglitazone |
en_US |
| dc.subject |
Rapamycin |
en_US |
| dc.subject |
Wortmannin |
en_US |
| dc.title |
Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart |
en_US |
| dc.type |
Article |
en_US |